Abstract The return of secondary genomic findings (ROSF) to participants in observational cohort studies has evolved from a topic of debate to an accepted standard. This Perspective synthesizes the proceedings of a 2024 National Heart, Lung and Blood Institute-sponsored workshop and the broader literature to provide updated guidance for ROSF.
Need an experienced lawyer in San Marcos? Call Morris & Wise to schedule a FREE 30-minute consultation to discuss your case.